Skip to main content

Advances in Cancer Screening and Detection: What PCPs Need to Know

A CME/AAFP-certified Activity

Click here to complete your registration.

If you will be watching the webinar in a group setting, please note all group participants will need to register individually in order to complete the post-test and evaluation to receive credit.


Wednesday, December 1, 2021
6:30 - 7:30 PM ET (5:30 - 6:30 PM CT / 3:30 - 4:30 PM PT)
Hosted by: Michigan Academy of Family Physicians

Welcome and Introduction
Optimizing Current Approaches to Early Cancer Detection
New Frontiers in Cancer Screening
Q & A Session and Activity Roundup

Early detection of cancer is the most effective method to improve outcomes and reduce mortality. Cancer screening programs can identify cancer in early stages, allowing early diagnosis and prolonged survival. Unfortunately, while screening techniques exist for some major cancers, most cancers to not have effective, validated screening measures. Patients with these cancers are often diagnosed at later stages, resulting in poor outcomes. In recent years, large-scale gene sequencing and analysis of cell-free DNA have been investigated as a method for early cancer diagnosis. While these tests are currently investigational, they have been shown to be highly effective in detecting cancer in early stages of disease.

This activity, Advances in Cancer Screening and Detection: What PCPs Need to Know, will review current standards for early cancer screening and detection as well as emerging molecular screening technologies for early cancer detection.


Donald A. Richards, MD, PhD
Medical Director/Research Director
Texas Oncology - Tyler
US Oncology Research
Tyler, TX

John J. Russell, MD, FAAFP
Chair, Department of Family Medicine
Director, Family Medicine Residency Program
Abington Memorial Hospital
Clinical Professor of Family and Community Medicine
Sidney Kimmel Medical College
Philadelphia, PA

This activity is intended for primary care physicians, the clinicians that are often involved in screening for and the early diagnosis of cancer.

At the conclusion of this activity, participants should be able to:

  • Discuss the risk of cancer and importance of cancer screening with your patients
  • Integrate currently available cancer screening programs into clinical practice
  • Describe the role of cell-free DNA in the early diagnosis of cancer
  • Evaluate emerging multi-cancer platforms for early cancer screening

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

The Potomac Center for Medical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For questions regarding CME credit or the evaluation, please email

The AAFP has reviewed Advances in Cancer Screening and Detection: What PCPs Need to Know, and deemed it acceptable for AAFP credit. Term of approval is from 06/04/2021 to 12/31/2021. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.

Disclosures will be made known to the participants prior to the start of the activity.

The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

To ensure your computer is compatible for the live event, please perform a system check by clicking on the link or by typing it into your internet browser. Please perform the system check on the same computer you will use for the live event. If your computer is compatible, you will receive a confirmation message on your screen and hear audio. Otherwise, please contact the Help Desk to resolve any issues.


  • 1.4 GHz Intel Pentium 4 or faster processor (or equivalent)
  • Windows 10, 8.1 (32-bit/64-bit), Windows 7 (32-bit/64-bit)
  • 512 MB of RAM (1 GB recommended)
  • Microsoft Internet Explorer 11 or later, Windows Edge browser, Mozilla Firefox, and Google Chrome
  • For HTML Client - Google Chrome (v70.0 & above), Mozilla Firefox (v65.0 & above), and Edge (v42.0 & above)
  • 1.83 GHz Intel Core Duo or faster processor
  • 512 MB RAM (1 GB recommended)
  • Mac OS X 10.12, 10.13 and 10.14
  • Mozilla Firefox, Apple Safari, Google Chrome
  • For HTML Client - Google Chrome (v70.0 & above), Apple Safari (v12.0 & above), and Mozilla Firefox (v65.0 & above)
  • The Adobe Connect app for iOS and Android requires Adobe Connect Server version 8.2 or later
  • Some features may not be enabled in all Adobe Connect meetings if one is using an Adobe Connect Server older than version 9.4.2 (required for Custom pods)
  • Google Android 4.4 or later
  • Apple iOS: iOS 8.1.2 or later
DSL/cable (wired connection recommended)

There is no fee for this activity. To receive credit, participants must register, view the live CME activity in its entirety, and then complete the post-test, with a score of 75% or better, and evaluation. The estimated time for completion of this activity is one hour. To receive a certificate, participants must demonstrate mastery of the presented material via the post-test. Participants are allowed to take the post-test multiple times.

Jointly provided by the Potomac Center for Medical Education and Rockpointe

This activity is supported by an educational grant from Grail, Inc.

PCME Privacy Policy